首页 > 市场调查报告书 > 医疗设备

药物递输设备包装/容器

市场调查报告书

商品编码

1382543

全球疫苗包装市场 - 2023-2030

Global Vaccine Packaging Market - 2023-2030

出版日期: 2023年11月17日 | 出版商:

DataM Intelligence | 英文 192 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球疫苗包装市场2022年达到13亿美元，预计2030年将达29亿美元，2023-2030年预测期间CAGR为13.2%。

疫苗接种是现代最重要的公共卫生干预措施之一。它在根除、控製或减少从天花到脊髓灰质炎等多种致命疾病的流行方面发挥了关键作用。然而，疫苗的功效不仅取决于背后的科学，还取决于其安全可靠的包装。

疫苗包装市场是一个充满活力的领域，涉及医疗保健、药品和包装材料领域。近年来，鑑于疫苗在 COVID-19 大流行期间受到关注，因为疫苗需要在特定温度范围内储存以保持其效力，因此其重要性得到了放大。

初级包装占1/3以上的市占率。同样，亚太地区在疫苗包装市场上占据主导地位，占据了超过 1/3 的最大市场份额。新兴经济体的疫苗接种机会不断增加以及关键参与者的存在是该地区主导的主要原因。

动力学

先进的冷链物流加上永续发展与环境议题

维持冷链对于疫苗的有效性至关重要。疫苗必须在特定温度下储存和运输，以防止变质。相应的事实导致了冷链物流和包装的进步。为了满足这项需求，Sonoco ThermoSafe 等公司推出了 Pegasus ULD 等创新包装解决方案，专为在精确温度下空运疫苗而设计。

此外，人们越来越重视永续性和环保的包装解决方案。各国政府和组织正在寻找不仅实用而且对环境负责的包装材料。 2021年，欧洲药品管理局（EMA）强调了环保疫苗包装的重要性。本公司已推出可回收和可生物降解的包装选项。

增加新兴市场获得疫苗的机会

疫苗的需求不仅限于已开发国家。随着人口和医疗保健需求的不断增长，新兴市场已成为疫苗包装产业的重要驱动力。各国政府和组织正在努力改善这些地区获得疫苗的机会，因此需要强大的包装解决方案。

例如，比尔和梅琳达盖兹基金会一直积极参与资助和支持发展中国家的疫苗接种计画。这些措施不仅在向新兴经济体提供疫苗方面发挥着至关重要的作用，而且还增加了对疫苗包装的需求，以将疫苗运送到这些新兴经济体。

全球疫苗接种工作不断加强

疫苗包装市场最重要的驱动力是全球疫苗接种的推动。随着 COVID-19 和其他疾病的疫苗接种活动，对高效、安全和可靠的疫苗包装的需求日益增长，以确保这些救生产品的功效。全球各国政府都在疫苗接种计画上投入大量资金。

例如，在美国，美国疾病管制与预防中心(CDC) 报告称，截至2021 年5 月，已接种了超过6.01 亿剂新冠肺炎(COVID-19) 疫苗。相应的统计数据表明，全球疫苗接种数量不断增加。因此，全球疫苗接种工作是市场的主要驱动力。

监理合规需求不断成长

疫苗包装须遵守全球卫生当局实施的严格规定。制定此类法规是为了确保疫苗的安全性和有效性。然而，合规性可能成为在该市场运营的公司的重大限制。满足监管要求需要在研究、开发和品质控制方面进行大量投资。

为了应对上述挑战，包装公司开发了符合监管标准的解决方案。例如，Schott AG 在 2020 年推出了 iQ 平台，该平台提供了全面的品质控制方法，帮助疫苗製造商在整个包装过程中保持合规性。

一系列冷链挑战

疫苗包装市场最重要的限制之一是需要在整个分销过程中保持冷链。许多疫苗，尤其是针对麻疹、腮腺炎、德国麻疹和 COVID-19 等疾病的疫苗，需要严格的温度控制才能保持有效。据世界卫生组织(WHO)称，全球每年有高达50%的疫苗可能因运输和储存过程中的温度控制问题而被浪费。

为了应对这些挑战，出现了一些创新。例如，2020 年，Sonoco ThermoSafe 推出了 Pegasus ULD，这是专为航空运输设计的温控货柜。该产品旨在透过为疫苗和其他温度敏感药品的安全运输提供可靠的解决方案来解决冷链问题。

Overview

Global Vaccine Packaging Market reached US$ 1.3 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 13.2% during the forecast period 2023-2030.

Vaccination is one of the most significant public health interventions of the modern era. It has played a pivotal role in eradicating, controlling or reducing the prevalence of numerous deadly diseases, from smallpox to polio. However, the efficacy of vaccines not only depends on the science behind them but also on their safe and secure packaging.

The vaccine packaging market is a dynamic sector that intersects the worlds of healthcare, pharmaceuticals and packaging materials. Its importance has been magnified in recent years, given the spotlight on vaccines during the COVID-19 pandemic as vaccines need to be stored within a specific temperature range to maintain their potency.

The primary packaging, accounts for over 1/3rd of the market share. Similarly, the Asia-Pacific dominates the vaccine packaging market, capturing the largest market share of over 1/3rd. Growing vaccination access to emerging economies and presence of key players are major reason behind the region's dominance.

Dynamics

Advanced Cold Chain Logistics coupled with Sustainability and Environmental Concerns

Maintaining the cold chain is crucial for vaccine effectiveness. Vaccines must be stored and transported at specific temperatures to prevent spoilage. The respective fact has led to advancements in cold chain logistics and packaging. In response to this need, companies like Sonoco ThermoSafe launched innovative packaging solutions such as Pegasus ULD, designed for air cargo shipments of vaccines at precise temperatures.

Moroever, there is a growing emphasis on sustainability and environmentally friendly packaging solutions. Governments and organizations are seeking packaging materials that are not only functional but also environmentally responsible. In 2021, the European Medicines Agency (EMA) emphasized the importance of eco-friendly vaccine packaging. Companies have responded with recyclable and biodegradable packaging options.

Increasing Access to Vaccines in Emerging Markets

The need for vaccines is not limited to developed countries. Emerging markets, with growing populations and healthcare needs, have become significant drivers in the vaccine packaging industry. Governments and organizations are working to improve access to vaccines in these regions, necessitating robust packaging solutions.

For example, the Bill and Melinda Gates Foundation has been actively involved in funding and supporting vaccine delivery initiatives in developing countries. Such initiatives play crucial role in not only making vaccines available to emerging economies, but also boosts the need for vaccine packaging to transport vaccines in to these emerging economies.

Growing Global Vaccination Efforts

The most significant driver in the vaccine packaging market is the global push for vaccination. With vaccination campaigns against COVID-19 and other diseases, there is a growing need for efficient, safe and secure vaccine packaging to ensure the efficacy of these life-saving products. Governments globally are investing heavily in vaccination programs.

For instance, in U.S., the Centers for Disease Control and Prevention (CDC) reported that more than 601 million COVID-19 vaccine doses had been administered by May 2021. The respective statistics is an indicator of growing vaccination throughout the world. Thus, global vaccination efforts acts major driver for the market.

Growing Need for Regulatory Compliance

Vaccine packaging is subject to stringent regulations imposed by health authorities globally. Such regulations are in place to ensure the safety and efficacy of vaccines. However, compliance can be a significant restraint for companies operating in this market. Meeting regulatory requirements demands substantial investments in research, development and quality control.

In response to the aforementioned challenges, packaging companies have developed solutions that meet regulatory standards. For instance, Schott AG introduced the iQ platform in 2020, which provides a comprehensive approach to quality control, helping vaccine manufacturers maintain compliance throughout the packaging process.

A series of Cold Chain Challenges

One of the most significant restraints in the vaccine packaging market is the need to maintain a cold chain throughout the distribution process. Many vaccines, especially those for diseases like measles, mumps, rubella and COVID-19, require strict temperature control to remain effective. According to the World Health Organization (WHO), up to 50% of vaccines may be wasted globally each year due to temperature control issues during transportation and storage.

In response to these challenges, several innovations have emerged. In 2020, for example, Sonoco ThermoSafe introduced the Pegasus ULD, a temperature-controlled container designed for air transport. The product aims to address cold chain issues by providing a reliable solution for the safe transport of vaccines and other temperature-sensitive pharmaceuticals.

Segment Analysis

The global vaccine packaging market is segmented based on type, level, end-user and region.

Growing need to ensure safe and effective distribution of vaccines

The global vaccine packaging market plays a crucial role in ensuring the safe and effective distribution of vaccines globally. Within this market, the segment dedicated to vaccine cool bags is of paramount importance. Such products are designed to maintain the required temperature for vaccines during transportation and storage, addressing one of the most critical challenges in vaccine distribution.

The World Health Organization (WHO) estimates that over 50% of vaccines are wasted each year due to temperature deviations. The startling figure emphasizes the need for robust temperature control measures during vaccine distribution. In U.S., the Centers for Disease Control and Prevention (CDC) has reported that vaccine wastage due to temperature issues can range from 25% to 50%.

The statistics from government sources highlight the challenges faced in vaccine distribution due to temperature deviations, emphasizing the need for effective temperature control solutions. As the world continues to grapple with the importance of vaccination in public health, vaccine cool bags play a pivotal role in ensuring that vaccines reach their intended recipients in safe and effective conditions.

Geographical Penetration

Increasing Vaccine Production, Rising Healthcare Awareness and A Growing Focus On Quality and Safety In the Pharmaceutical Sector

Asia-Pacific has emerged as a key player in the global vaccine packaging market, driven by a combination of factors including increasing vaccine production, rising healthcare awareness and a growing focus on quality and safety in the pharmaceutical sector. The importance of vaccine packaging cannot be overstated. It plays a crucial role in preserving the potency and efficacy of vaccines, ensuring that they reach patients in optimal condition.

Asia-Pacific has rapidly evolved into a hub for vaccine production. With countries such as India and China at the forefront, the region manufactures a significant portion of the world's vaccines. The respective development has naturally spurred growth in the vaccine packaging sector. Moreover, government investments and initiatives aimed at bolstering the pharmaceutical sector have further fueled the vaccine packaging market's growth.

While the Asia-Pacific has made significant strides in vaccine packaging, it's not without its challenges. Ensuring the quality and safety of vaccine packaging materials, as well as meeting the increasing demand for vaccines, are ongoing concerns. However, with government support, private sector innovation and a growing awareness of the importance of vaccine packaging, the Asia-Pacific is poised for continued growth in this vital sector.

Competitive Landscape

The major global players in the market are: Gerresheimer AG, West Pharmaceutical Services, Inc, Becton, Dickinson & Company, SCHOTT AG, SGD S.A., Catalent, Inc, Stevanato Group, Nipro Corporation, Piramal Glass Private Limited and UDG Healthcare plc.

COVID-19 Impact Analysis

The COVID-19 pandemic, which began in late 2019, has had profound effects on every aspect of our lives, including the healthcare and pharmaceutical industries. One of the critical components of the global response to the pandemic has been the development and distribution of vaccines. The vaccine packaging industry plays a pivotal role in ensuring the safe and efficient delivery of vaccines globally.

The COVID-19 pandemic triggered an unprecedented global demand for vaccines. Pharmaceutical companies raced to develop vaccines to combat the virus, leading to a significant increase in vaccine production. The respective surge in vaccine production, in turn, had a direct impact on the vaccine packaging market.

According to U.S. Food and Drug Administration (FDA), as of December 2020, over 250 COVID-19 vaccine candidates were in various stages of development. The aforementioned statistics is translated to an enormous demand for vaccine packaging materials such as vials, ampoules, syringes and vial seals. Companies were forced to develop packaging solutions that could ensure the safe storage and transportation of vaccines at various temperature requirements.

Russia-Ukraine War Impact Analysis

Armed conflicts in key manufacturing regions, such as Ukraine, can disrupt global supply chains. Ukraine, for example, is known for its production of pharmaceutical and chemical products, including packaging materials. Any interruptions in the supply of materials from conflict zones can lead to shortages and increased prices for packaging materials, affecting vaccine production and distribution.

Further, global supply chain disruptions often lead to increased transportation and logistics costs. Manufacturers may need to find alternative suppliers or transportation routes, which can result in higher expenses. Such increased costs may be passed on to consumers, healthcare providers and governments purchasing vaccines.

Moroever, the eopolitical instability can also lead to regulatory challenges. Regulatory agencies in various countries may impose stricter controls or inspections on products originating from or passing through conflict zones. Such additional requirements can create delays in getting vaccines to market.

By Type

Vaccine Cool Bags
Vials and Ampoules
Corrugated Boxes
Others

By Level

Primary
Secondary
Tertiary

By End-User

Biopharmaceutical Companies
Hospitals
Medical Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In 2023, Va-Q-tec, a portable and reusable temperature-controlled packaging solution lunched COOLPACK, a vaccine cool bag designed for the safe transportation of vaccines, particularly in regions with limited infrastructure. The COOLPACK's innovative design allows it to maintain temperature for extended periods, addressing the challenges of vaccine distribution in remote areas.
In 2021, Sonoco ThermoSafe introduced the Pegasus ULD, a unit load device designed for the air transportation of temperature-sensitive pharmaceuticals, including vaccines. The product features advanced insulation and phase change materials, ensuring precise temperature control and protection during air travel, which is crucial for the global distribution of vaccines.
Softbox introduced the Tempcell ECO in 2022. The product is a single-use, fully-recyclable packaging solution, designed for the transportation of temperature-sensitive pharmaceuticals and vaccines. It offers temperature control for up to 168 hours, making it ideal for long-distance vaccine distribution.

Why Purchase the Report?

To visualize the global vaccine packaging market segmentation based on type, level, end-user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of vaccine packaging market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global vaccine packaging market report would provide approximately 61 tables, 59 figures and 192 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Level
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Advanced Cold Chain Logistics coupled with Sustainability and Environmental Concerns
  - 4.1.1.2. Increasing Access to Vaccines in Emerging Markets
  - 4.1.1.3. Growing Global Vaccination Efforts
- 4.1.2. Restraints
  - 4.1.2.1. Growing Need for Regulatory Compliance
  - 4.1.2.2. A series of Cold Chain Challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Vaccine Cool Bags*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Vials and Ampoules
7.4. Corrugated Boxes
7.5. Others

8. By Level

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
- 8.1.2. Market Attractiveness Index, By Level
8.2. Primary*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Secondary
8.4. Tertiary

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Biopharmaceutical Companies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hospitals
9.4. Medical Laboratories
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Russia
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Gerresheimer AG*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. West Pharmaceutical Services, Inc
12.3. Becton, Dickinson & Company
12.4. SCHOTT AG
12.5. SGD S.A.
12.6. Catalent, Inc
12.7. Stevanato Group
12.8. Nipro Corporation
12.9. Piramal Glass Private Limited
12.10. UDG Healthcare plc

LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格